Mark J Levis


1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mark J Levis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

FLT3 inhibitors added to induction therapy induce deeper remissions

Levis, M., Shi, W., Chang, K., Laing, C., Pollner, R., Gocke, C., Adams, E., Berisha, F., Lameh, J. & Lesegretain, A., Jan 1 2020, In : Blood. 135, 1, p. 75-78 4 p.

Research output: Contribution to journalLetter

Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS

Zeidner, J. F., Knaus, H. A., Zeidan, A. M., Blackford, A. L., Montiel-Esparza, R., Hackl, H., Prince, G. T., Gondek, L. P., Ghiaur, G., Showel, M. M., DeZern, A. E., Pratz, K. W., Douglas Smith, B., Levis, M. J., Gore, S., Coombs, C. C., Foster, M. C., Streicher, H., Karp, J. E., Luznik, L. & 1 others, Gojo, I., Jan 1 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

  • Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study

    Kayser, S., Rahmé, R., Martínez-Cuadrón, D., Ghiaur, G., Thomas, X., Sobas, M., Guerci-Bresler, A., Garrido, A., Pigneux, A., Gil, C., Raffoux, E., Tormo, M., Vey, N., de la Serna, J., Salamero, O., Lengfelder, E., Levis, M. J., Fenaux, P., Sanz, M. A., Platzbecker, U. & 3 others, Schlenk, R. F., Adès, L. & Montesinos, P., Jan 1 2020, (Accepted/In press) In : Leukemia.

    Research output: Contribution to journalArticle

  • Arsenic and old FLT3

    Levis, M. J., Mar 28 2019, In : Blood. 133, 13, p. 1392-1393 2 p.

    Research output: Contribution to journalArticle